ALNY logo

Alnylam Pharmaceuticals (ALNY) Accounts payable

annual accounts payable:

$88.42M+$32.90M(+59.25%)
December 31, 2024

Summary

  • As of today (May 29, 2025), ALNY annual accounts payable is $88.42 million, with the most recent change of +$32.90 million (+59.25%) on December 31, 2024.
  • During the last 3 years, ALNY annual accounts payable has risen by +$14.99 million (+20.41%).
  • ALNY annual accounts payable is now -9.87% below its all-time high of $98.09 million, reached on December 31, 2022.

Performance

ALNY Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

quarterly accounts payable:

$97.40M+$8.98M(+10.16%)
March 31, 2025

Summary

  • As of today (May 29, 2025), ALNY quarterly accounts payable is $97.40 million, with the most recent change of +$8.98 million (+10.16%) on March 31, 2025.
  • Over the past year, ALNY quarterly accounts payable has increased by +$19.25 million (+24.63%).
  • ALNY quarterly accounts payable is now -0.71% below its all-time high of $98.09 million, reached on December 31, 2022.

Performance

ALNY quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherALNYbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

ALNY Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+59.3%+24.6%
3 y3 years+20.4%+77.4%
5 y5 years+77.2%+140.6%

ALNY Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-9.9%+59.3%-0.7%+140.1%
5 y5-year-9.9%+77.2%-0.7%+272.8%
alltimeall time-9.9%>+9999.0%-0.7%>+9999.0%

ALNY Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$97.40M(+10.2%)
Dec 2024
$88.42M(+59.3%)
$88.42M(+24.9%)
Sep 2024
-
$70.81M(-4.3%)
Jun 2024
-
$73.98M(-5.3%)
Mar 2024
-
$78.15M(+40.8%)
Dec 2023
$55.52M(-43.4%)
$55.52M(-24.8%)
Sep 2023
-
$73.84M(+23.6%)
Jun 2023
-
$59.75M(-4.0%)
Mar 2023
-
$62.24M(-36.6%)
Dec 2022
$98.09M(+33.6%)
$98.09M(+141.8%)
Sep 2022
-
$40.57M(-22.6%)
Jun 2022
-
$52.42M(-4.5%)
Mar 2022
-
$54.92M(-25.2%)
Dec 2021
$73.43M(+41.3%)
$73.43M(+83.3%)
Sep 2021
-
$40.05M(-24.6%)
Jun 2021
-
$53.08M(+17.0%)
Mar 2021
-
$45.38M(-12.7%)
Dec 2020
$51.97M(+4.2%)
$51.97M(+86.4%)
Sep 2020
-
$27.87M(+6.7%)
Jun 2020
-
$26.13M(-35.5%)
Mar 2020
-
$40.48M(-18.8%)
Dec 2019
$49.88M(-16.5%)
$49.88M(+26.6%)
Sep 2019
-
$39.39M(-44.7%)
Jun 2019
-
$71.22M(+214.1%)
Mar 2019
-
$22.67M(-62.0%)
Dec 2018
$59.71M(+110.6%)
$59.71M(+174.2%)
Sep 2018
-
$21.77M(+81.6%)
Jun 2018
-
$11.99M(-9.2%)
Mar 2018
-
$13.21M(-53.4%)
Dec 2017
$28.36M(-47.9%)
$28.36M(+206.9%)
Sep 2017
-
$9.24M(-60.1%)
Jun 2017
-
$23.17M(-8.7%)
Mar 2017
-
$25.37M(-53.4%)
Dec 2016
$54.47M(+224.4%)
$54.47M(+135.4%)
Sep 2016
-
$23.14M(+80.4%)
Jun 2016
-
$12.82M(-26.5%)
Mar 2016
-
$17.44M(+3.9%)
Dec 2015
$16.79M(+11.1%)
$16.79M(+17.6%)
Sep 2015
-
$14.27M(-9.2%)
Jun 2015
-
$15.71M(+1.5%)
Mar 2015
-
$15.49M(+2.5%)
Dec 2014
$15.11M
$15.11M(+190.5%)
Sep 2014
-
$5.20M(-15.7%)
DateAnnualQuarterly
Jun 2014
-
$6.17M(+22.5%)
Mar 2014
-
$5.04M(-14.6%)
Dec 2013
$5.90M(+33.4%)
$5.90M(+116.1%)
Sep 2013
-
$2.73M(-39.8%)
Jun 2013
-
$4.53M(+46.0%)
Mar 2013
-
$3.10M(-29.8%)
Dec 2012
$4.42M(-23.8%)
$4.42M(-13.2%)
Sep 2012
-
$5.09M(-7.7%)
Jun 2012
-
$5.52M(+27.2%)
Mar 2012
-
$4.34M(-25.2%)
Dec 2011
$5.80M(-37.7%)
$5.80M(+5.7%)
Sep 2011
-
$5.49M(-31.0%)
Jun 2011
-
$7.95M(+37.1%)
Mar 2011
-
$5.80M(-37.7%)
Dec 2010
$9.31M(-25.4%)
$9.31M(+41.9%)
Sep 2010
-
$6.56M(-36.9%)
Jun 2010
-
$10.40M(+48.8%)
Mar 2010
-
$6.99M(-44.0%)
Dec 2009
$12.49M(+382.6%)
$12.49M(+48.2%)
Sep 2009
-
$8.43M(+30.4%)
Jun 2009
-
$6.46M(-26.0%)
Mar 2009
-
$8.73M(+237.3%)
Dec 2008
$2.59M(-32.4%)
$2.59M(-22.6%)
Sep 2008
-
$3.34M(-46.4%)
Jun 2008
-
$6.24M(-31.3%)
Mar 2008
-
$9.08M(+137.4%)
Dec 2007
$3.83M(-6.3%)
$3.83M(-45.8%)
Sep 2007
-
$7.06M(+24.5%)
Jun 2007
-
$5.67M(+88.5%)
Mar 2007
-
$3.01M(-26.4%)
Dec 2006
$4.08M(+106.8%)
$4.08M(+66.3%)
Sep 2006
-
$2.46M(-33.6%)
Jun 2006
-
$3.70M(-5.9%)
Mar 2006
-
$3.93M(+98.9%)
Dec 2005
$1.98M(+117.0%)
$1.98M(-0.5%)
Sep 2005
-
$1.99M(+23.1%)
Jun 2005
-
$1.61M(-2.5%)
Mar 2005
-
$1.65M(+81.6%)
Dec 2004
$910.00K(-39.7%)
$910.00K(-37.2%)
Sep 2004
-
$1.45M(-19.9%)
Jun 2004
-
$1.81M(-50.2%)
Mar 2004
-
$3.64M(+140.8%)
Dec 2003
$1.51M(+124.0%)
$1.51M
Dec 2002
$674.00K
-

FAQ

  • What is Alnylam Pharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals annual accounts payable year-on-year change?
  • What is Alnylam Pharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Alnylam Pharmaceuticals?
  • What is Alnylam Pharmaceuticals quarterly accounts payable year-on-year change?

What is Alnylam Pharmaceuticals annual accounts payable?

The current annual accounts payable of ALNY is $88.42M

What is the all time high annual accounts payable for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high annual accounts payable is $98.09M

What is Alnylam Pharmaceuticals annual accounts payable year-on-year change?

Over the past year, ALNY annual accounts payable has changed by +$32.90M (+59.25%)

What is Alnylam Pharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of ALNY is $97.40M

What is the all time high quarterly accounts payable for Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals all-time high quarterly accounts payable is $98.09M

What is Alnylam Pharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, ALNY quarterly accounts payable has changed by +$19.25M (+24.63%)
On this page